Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

not under control, the government's chief scientist said, as Boris Johnson warned tighter rules may be needed." Government Chief Scientific Adviser Patrick Valiance said, "Numbers of cases are going up, hospitalizations are going up, ICUs are going up, and unfortunately, very sadly so are deaths. We don't have t

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

not under control, the government's chief scientist said, as Boris Johnson warned tighter rules may be needed." Government Chief Scientific Adviser Patrick Valiance said, "Numbers of cases are going up, hospitalizations are going up, ICUs are going up, and unfortunately, very sadly so are deaths. We don't have

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

not under control, the government's chief scientist said, as Boris Johnson warned tighter rules may be needed." Government Chief Scientific Adviser Patrick Valiance said, "Numbers of cases are going up, hospitalizations are going up, ICUs are going up, and unfortunately, very sadly so are deaths. We don't have

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

not under control, the government's chief scientist said, as Boris Johnson warned tighter rules may be needed." Government Chief Scientific Adviser Patrick Valiance said, "Numbers of cases are going up, hospitalizations are going up, ICUs are going up, and unfortunately, very sadly so are deaths. We don't have